Costs of inflammatory bowel disease in Germany

PharmacoEconomics

Volumn 24, Issue 8, 2006, Pages 797-814

  Stark, Renee ^a   König, Hans Helmut ^b   Leidl, Reiner ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROHN DISEASE; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; ENTERITIS; FEMALE; GERMANY; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL LEAVE; MEDICAL SOCIETY; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETIREMENT; ULCERATIVE COLITIS;

ADULT; AGED; COST OF ILLNESS; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED;

EID: 33747198336     PISSN: 11707690     EISSN: 11707690     Source Type: Journal    
DOI: 10.2165/00019053-200624080-00006     Document Type: Article

References (61)

1. Martins NB, Peppercorn MA. Inflammatory bowel disease. Am J Managed Care 2004; 10 (8): 544-52
2. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39 (5): 690-7
3. Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004; 53 (10): 1471-8
4. de Boer AG, Sprangers MA, Bartelsman JF, et al. Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study. Eur J Gastroenterol Hepatol 1998; 10 (9): 783-9
5. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl. 5: V1-16
6. Rubin GP, Hungin AP, Kelly PJ, et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000; 14 (12): 1553-9
7. Ebinger M, Leidl R, Thomas S, et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol 2004; 19 (2): 192-9
8. Beiche A, Konig HH, Ebinger M, et al. Costs of ambulant care for patients with inflammatory bowel disease in general practice [in German]. Z Gastroenterol 2003; 41 (6): 527-36
9. Rosch M, Leidl R, Tirpitz C, et al. Cost measurement based on a cost diary in patients with inflammatory bowel disease [in German]. Z Gastroenterol 2002; 40 (4): 217-28
10. Metge CJ, Blanchard JF, Peterson S, et al. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001; 96 (12): 3348-55
11. Jaisson-Hot I, Flourie B, Descos L, et al. Management for severe Crohn's disease: a lifetime cost-utility analysis. Int J Technol Assess Health Care 2004; 20 (3): 274-9
12. Dubinsky MC, Reyes E, Ofman J, et al. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Am J Gastroenterol 2005; 100 (10): 2239-47
13. Hansson L, Lloyd A, Anderson P, et al. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002; 11 (1): 35-45
14. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992; 14 (4): 309-17
15. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122 (5): 1500-11
16. Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997; 32 (11): 1134-9
17. Goossens ME, Rutten-van Molken MP, Vlaeyen JW, et al. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53 (7): 688-95
18. Becker A, Seitz R, Jacobi E, et al. Cost evaluation by a patient questionnaire: pilot study of a weekly cost diary [in German]. Rehabilitation (Stuttg) 2001; 40 (1): 12-20
19. Verbrugge LM. Health diaries. Med Care 1980; 18 (1): 73-95
20. Mauskopf J, Schulman K, Bell L, et al. A strategy for collecting pharmacoeconomic data during phase II/III clinical trials. Pharmacoeconomics 1996; 9 (3): 264-77
21. Johnston K, Buxton MJ, Jones DR, et al. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999; 3 (6): 1-76
22. Best BJ, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44
23. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82-6
24. Verband Deutscher Rentenversicherungsträger. Förderschwerpunkt "Rehabilitationswissenschaften": Empfehlungen der Arbeitsgruppen "Generische Methoden", "Routinedaten" und "Reha-Ökonomie". Bad Homburg: WDV Wirtschaftsdienst, 1999
25. Krauth C, Hessel F, Hansmeier T, et al. Empirical standard costs for health economic evaluation in Germany: a proposal by the working group methods in health economic evaluation [in German]. Gesundheitswesen 2005; 67 (10): 736-46
26. Paracelsus heilpraktikerschulen. German billing guidelines for naturopaths [online]. Available from URL: http://www.paracelsus.de/recht/hp_geb. html [Accessed 2005 Jul 22]
27. Federation of Public Health Insurance Companies of Employees (VDAK). Reimbursement of physiotherapy (west) [online]. Available from URL: http://www.vdak.de/heil_hilfsmittel/physio/verguetungsliste_physio_west.pdf [Accessed 2005 Jul 22]
28. Federation of Public Health Insurance Companies of Employees (VDAK). Reimbursement of physiotherapy (east) [online]. Available from URL: http://www.vdak.de/heil_hilfsmittel/physio/verguetungsliste_physio_ost.pdf [Accessed 2005 Jul 22]
29. Bundes-Angestelltentarifvertrag (BAT) [online]. Available from URL: http://www.hu-berlin.de/personalrat/battext/bat_0.htm [Accessed 2006 Mar 17]
30. BAT payment system: Vergütungsordnung zum BAT (Bundes- Angestelltentarifvertrag) [online]. Available from URL: http://www.uni- tuebingen.de/uni/qqp/mta-Angestellte.htm [Accessed 2006 Mar 20]
31. Research Institute of the AOK [online]. Available from URL: http://wido.de/arzneimittel.html [Accessed 2006 Mar 20]
32. EURO-MED-STAT: monitoring expenditure and utilization of medicinal products in the European Union countries. A public health approach. Eur J Public Health 2003; 13 (3 Suppl.): 95-100
33. Bundesministerium für Gesundheit. Daten des Gesundheitswesen 2001. Baden-Baden: Nomos Verlagsgesellschaft, 2001
34. Federal Statistical Office Germany. Reihe 6.3: account of hospital costs in 2001(in German) [online]. Available from URL: http://www.ec.destatis.de/csp/ shop/sfg/bpm.html.cms.cBroker.cls?.cmspath=struktur,sfgsuchergebnis. csp&action=newsearch&op_EVASNr=startswith&search_EVASNr=2312 [Accessed 2006 Jan 26]
35. Internet Pharmacy [online]. Available from URL: http://www.apondo.de/ assura-basisplatten-10-35mm-m-guertelbef-2884-2081971/ [Accessed 2005 May 4]
36. Federal Statistical Office Germany. Press release regarding wages and salaries in 2001(in German) [online]. Available from URL: http://www.destatis. de/presse/deutsch/pk/2003/loehne_gehaelter_2001_neu.pdf [Accessed 2005 Jul 28]
37. Federal Statistical Office Germany. Brochure regarding the development of labour costs [online]. Available from URL: http://www-ec.destatis.de/cps/shop/ sfg/vollanzeige.csp?ID=1016383&CSPCHD=00000001000431s4f3M0003400713556 [Accessed 2005 Jul 28]
38. Welte RJJ, Leidl R. MICE (Module for standardized Indirect Cost Estimation) increases the transferability of results [abstract]. Value Health 2001; 4 (6): 429
39. Welte R, König HH, Jager J, et al. Assessment of indirect costs of injecting drug use: which methods should be employed? In: Jager J, Limburg W, Kretzschmar M, et al, editors. Hepatitis C and injecting drug use: impact, costs and policy options. Luxembourg: Office for Official Publications of the European Communities, 2004: 249-67
40. Bach H-U, Gaggermeier C, Kettner A, et al. IAB-Kurzbericht Nr. 17/2004; Deutschland: Entwicklung des Arbeitsmarktes im Jahr 2005 [online]. Available from URL: http://www.iab.de/asp/internet/dbdokShow.asp?.pkyDoku=k041112n01 [Accessed 2004 Jul 4]
41. Federal Ministry of Education and Research. Basic and structural data 2005 [online]. Available from URL: http://www.bmbf.de/pub/GuS_2005_ges_engl.pdf [Accessed 2006 Jan 26]
42. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326 (7382): 219
43. Wolfe R, Hanley J. If we're so different, why do we keep overlapping? When 1 plus 1 doesn't make 2. CMAJ 2002; 166 (1): 65-6
44. Bland JM, Peacock J. Interpreting statistics with confidence. Obstet Gynaecol 2002; 4 (3): 176-80
45. Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol 1992; 14 (4): 318-27
46. Statistics Sweden. Inflation in Sweden 1831-2004 [online]. Available from URL: http://www.scb.se/Statistik/PR/PR0101/2005M01/PR0101_2005M01_DI_06-07_EN. xls [Accessed 2005 Aug 19]
47. National Statistics UK. Harmonised index of consumer prices (HICP) 1991-2005 [online]. Available from URL: http://www.statistics.gov.uk/STATBASE/ tsdataset.asp?.vlnk=340 [Accessed 2005 Aug 19]
48. GPEC Information Center. US inflation rate [online]. Available from URL: http://www.gpec.org/InfoCenter/Topics/Economy/USInflation.html [Accessed 2005 Aug 19]
49. OECD Health Data 2005: statistics and indicators for 30 countries [CD]. Paris: OECD Publishing, 2005
50. Timmer A. Health economic aspects of inflammatory bowel disease [in German]. Gesundh Ökon Qual Manag 2000; 5: 54-66
51. German guidelines for Crohn's disease [online]. Available from URL: http://www.uni-duesseldorf.de/WWW/AWMF/ll/021-004.htm [Accessed 2005 Jul 12]
52. German guidelines for ulcerative colitis [online]. Available from URL: http://www.uni-duesseldorf.de/WWW/AWMF/ll/021-009.htm [Accessed 2005 Jul 12]
53. Verband Deutscher Rentenversicherungsträger. VDR-Statistik Rentenzugang: des Jahres 2003 einschließlich Rentenwegfall, Rentenänderung/Änderung des Teilrentenanteils in der deutschen gesetzlichen Rentenversicherung. VDR: Frankfurt am Main, 2004
54. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003; 98 (5): 1064-72
55. Cohen RD. IBD indirect costs: the sleeping giant? Gastroenterology 2003; 125 (3): 982-4
56. John J, Holle R. Problems of building up and using statutory health insurance data for population-based economic evaluation studies: experiences from KORA [in German]. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 2003; 34 (2): 96-111
57. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149 (10): 916-24
58. Roberts RO, Bergstralh EJ, Schmidt L, et al. Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 1996; 49 (9): 989-95
59. Ritter PL, Stewart AL, Kaymaz H, et al. Self-reports of health care utilization compared to provider records. J Clin Epidemiol 2001; 54 (2): 136-41
60. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics 2002; 20 (10): 639-52
61. Deutsche Krankenhausgesellschaft. DKG-NT, Tarif der Deutschen Krankenhausgesellschaft für die Abrechnung erbrachter Leistungen und für die Kostenerstattung vom Arzt an das Krankenhaus. Stuttgart: Kohlhammer, 2002